Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 4Phase 3 3Phase 2 1

Status

Completed 7Unknown 3Recruiting 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Breast 1

Conditions

Vesico-Ureteral Reflux 1Ureteral Neoplasms 1Nephrolithiasis 1Lung Neoplasms 1Kidney Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 90Gemcitabine 81Paclitaxel 80Docetaxel 73Capecitabine 64Oxaliplatin 53Specimen Handling 52Fluorouracil 52Magnetic Resonance Spectroscopy 50Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 44Leucovorin 39Drug Therapy 39Irinotecan 37Doxorubicin 36Pemetrexed 35Injections 30Trastuzumab 28Vincristine 27Rituximab 27Radiosurgery 25Prednisone 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Bupivacaine × Clear all
NCT06810375 2026-04-09

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

George Washington University

Phase 3 Recruiting
120 enrolled
Thoracic

Lung Neoplasms

NCT06349668 2026-02-05

SMILe

University Hospital, Linkoeping

Phase 3 Recruiting
220 enrolled
Genitourinary

Kidney Neoplasms, Ureteral Neoplasms, Vesico-Ureteral Reflux, Nephrolithiasis

NCT03351348 2025-08-26

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting
165 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡